ROS, E. O. (2021) “The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited”, Reactive Oxygen Species, 11, pp. n7–n8. doi: 10.20455/ros.2021.n.807.